SCHEMBL30363232

SCHEMBL30363232

C#CCSc1ccc2cc(SCC#C)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
CA4 P22748 1/20 0.50
RAB9A P51151 4/20 0.36
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ANPEP P15144 1/20 0.35
ALOX15 P16050 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 2/20 0.33
CYP3A4 P08684 1/20 0.33
HIF1A Q16665 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 2/20 0.33
HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13301431 0.92 ANPEP (0.46) CA12CA1CA2CA9CA4
SCHEMBL11630354 0.79 CA12 (0.49) CA12CA1CA2CA9CA4
SCHEMBL5178079 0.74 CA12 (0.53) CA12CA1CA2CA9CA4
SCHEMBL6152469 0.74 ALDH1A1 (0.53) CA12CA1CA2CA9CA4
SCHEMBL726899 0.73 ALDH1A1 (0.52) CA12CA1CA2CA9CA4
SCHEMBL20873387 0.73 MTNR1B (0.49) CA1CA2CA9RAB9ACYP3A4
SCHEMBL20873370 0.73 GRM5 (0.50) CA12CA1CA2CA9CA4
SCHEMBL31335176 0.71 CA12 (0.50) CA12CA1CA2CA9CA4
SCHEMBL4156797 0.70 CA12 (0.38) CA12CA1CA2CA9CA4
SCHEMBL31335132 0.70 ENPP2 (0.39) CA12CA1CA2CA9CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109101-A1 NAPHTHALENE COMPOUND, SYNTHESIS METHOD THEREFOR, AND COMPOSITION CONTAINING SAID NAPHTHALENE COMPOUND SHIKOKU CHEMICALS CORPORATION (JP) 2025-04-03 US disclosed
EP-4464691-A2 NAPHTHALENE COMPOUND, SYNTHESIS METHOD THEREFOR, AND COMPOSITION CONTAINING SAID NAPHTHALENE COMPOUND Shikoku Chemicals Corporation (JP) 2024-11-20 EP disclosed
CN-118541350-A Naphthalene compound, method for synthesizing the same, and composition containing the same 四国化成工业株式会社 2024-08-23 CN disclosed
WO-2023058781-A2 NAPHTHALENE COMPOUND, SYNTHESIS METHOD THEREFOR, AND COMPOSITION CONTAINING SAID NAPHTHALENE COMPOUND 四国化成工業株式会社 2023-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109101-A1 NAPHTHALENE COMPOUND, SYNTHESIS METHOD THEREFOR, AND COMPOSITION CONTAINING SAID NAPHTHALENE COMPOUND C1S, CDH1, L1CAM CA12 805/4885CA1 1410/4885CA2 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.